{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:55:02Z","timestamp":1778291702105,"version":"3.51.4"},"reference-count":92,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["GA. no. 14548"],"award-info":[{"award-number":["GA. no. 14548"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GILEAD Sciences Hellas","award":["2017 ASKLEPIOS Donations Program"],"award-info":[{"award-number":["2017 ASKLEPIOS Donations Program"]}]},{"name":"Hellenic Association for the Study of the Liver","award":["Research Protocol 203\/2015"],"award-info":[{"award-number":["Research Protocol 203\/2015"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Host lipid metabolism reprogramming is essential for hepatitis C virus (HCV) infection and progression to severe liver disease. Direct-acting antivirals (DAAs) achieve a sustained virological response (SVR) in most patients, but virus eradication does not always protect against hepatocellular carcinoma (HCC). Angiopoietin-like protein-3 (ANGPTL-3) and angiopoietin-like protein-4 (ANGPTL-4) regulate the clearance of plasma lipids by inhibiting cellular lipase activity and possess emerging roles in tumourigenesis. We used ELISA and RT-qPCR to investigate ANGPTL-3 and ANGPTL-4 expression in HCV patients with characterised fibrosis throughout the natural history of hepatitis C and in long-term HCV infection in vitro, before and after DAA treatment. ANGPTL-3 was decreased in patients with advanced fibrosis compared to other disease stages, while ANGPTL-4 was progressively increased from acute infection to cirrhosis and HCC, peaking at the advanced fibrosis stage. Only ANGPTL-3 mRNA was down-regulated during early infection in vitro, although both ANGPTLs were increased later. DAA treatment did not alter ANGPTL-3 levels in advanced fibrosis\/cirrhosis and in HCV infection in vitro, in contrast to ANGPTL-4. The association between ANGPTLs and fibrosis in HCV infection was underlined by an inverse correlation between the levels of ANGPTLs and serum transforming growth factor- \u03b2 (TGF-\u03b2). Collectively, we demonstrate the pivotal role of advanced fibrosis in defining the expression fate of ANGPTLs in HCV infection and after treatment and propose a role for ANGPTL-3 as a contributor to post-treatment deregulation of lipid metabolism that could predispose certain individuals to HCC development.<\/jats:p>","DOI":"10.3390\/ijms22157961","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T09:25:52Z","timestamp":1627291552000},"page":"7961","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment"],"prefix":"10.3390","volume":"22","author":[{"given":"Vaia","family":"Valiakou","sequence":"first","affiliation":[{"name":"Molecular Virology Laboratory, Hellenic Pasteur Institute, 11521 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Eliadis","sequence":"additional","affiliation":[{"name":"Molecular Biology and Immunobiotechnology Laboratory, Hellenic Pasteur Institute, 11521 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Karamichali","sequence":"additional","affiliation":[{"name":"Molecular Virology Laboratory, Hellenic Pasteur Institute, 11521 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-0740","authenticated-orcid":false,"given":"Ourania","family":"Tsitsilonis","sequence":"additional","affiliation":[{"name":"Department of Biology, National and Kapodistrian University of Athens (NKUA), 15784 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Koskinas","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Medical School of Athens, Hippokration Hospital, 11521 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2784-3695","authenticated-orcid":false,"given":"Urania","family":"Georgopoulou","sequence":"additional","affiliation":[{"name":"Molecular Virology Laboratory, Hellenic Pasteur Institute, 11521 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6888-7678","authenticated-orcid":false,"given":"Pelagia","family":"Foka","sequence":"additional","affiliation":[{"name":"Molecular Virology Laboratory, Hellenic Pasteur Institute, 11521 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.14011","article-title":"Hepatitis C: Is eradication possible?","volume":"39","author":"Lombardi","year":"2019","journal-title":"Liver Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"Natural History of Hepatitis C","volume":"44","author":"Lingala","year":"2015","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3748\/wjg.15.5014","article-title":"Steatosis and insulin resistance in hepatitis C: A way out for the virus?","volume":"15","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/labinvest.2012.88","article-title":"Liver X receptor \u03b1-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication","volume":"92","author":"Cabello","year":"2012","journal-title":"Lab. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cmi.2016.09.017","article-title":"Role of assessing liver fibrosis in management of chronic hepatitis C virus infection","volume":"22","author":"Carmona","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/cr.2009.73","article-title":"Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells","volume":"19","author":"Wobser","year":"2009","journal-title":"Cell Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/JHC.S221187","article-title":"Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment","volume":"7","author":"Dash","year":"2020","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-Induced Epigenetic Changes Associated with Liver Cancer Risk Persist After Sustained Virologic Response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Virz\u00ec, A., Suarez, A.A.R., Baumert, T.F., and Lupberger, J. (2018). Oncogenic Signalling Induced by HCV Infection. Viruses, 10.","DOI":"10.3390\/v10100538"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"Lau","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/iub.1378","article-title":"Treg-specific demethylated region activity in isolated regulatory t lymphocytes is a surrogate for disease severity in hepatocellular carcinoma","volume":"67","author":"Liu","year":"2015","journal-title":"IUBMB Life"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12772","DOI":"10.1111\/cpr.12772","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review","volume":"53","author":"Hu","year":"2020","journal-title":"Cell Prolif."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/14728222.2019.1615883","article-title":"Aberrant lipid metabolism as a therapeutic target in liver cancer","volume":"23","author":"Pope","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sangineto, M., Villani, R., Cavallone, F., Romano, A., Loizzi, D., and Serviddio, G. (2020). Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12061419"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"581863","DOI":"10.3389\/fcell.2020.581863","article-title":"Transcriptomic Data Analyses Reveal a Reprogramed Lipid Metabolism in HCV-Derived Hepatocellular Cancer","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3350\/cmh.2020.0018","article-title":"Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy","volume":"26","author":"Huang","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2020.10.016","article-title":"HCC surveillance after SVR in patients with F3\/F4 fibrosis","volume":"74","author":"Ioannou","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2019.07.033","article-title":"Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores","volume":"157","author":"Ioannou","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Perez, S., Kaspi, A., Domovitz, T., Davidovich, A., Lavi-Itzkovitz, A., Meirson, T., Holmes, J.A., Dai, C.-Y., Huang, C.-F., and Chung, R.T. (2019). Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals. PLoS Genet., 15.","DOI":"10.1371\/journal.pgen.1008181"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Polyak, S.J., Crispe, I.N., and Baumert, T.F. (2021). Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure. Pathology, 10.","DOI":"10.3390\/pathogens10010044"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Rinaldi, L., Nevola, R., Franci, G., Perrella, A., Corvino, G., Marrone, A., Berretta, M., Morone, M.V., Galdiero, M., and Giordano, M. (2020). Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics. Cancers, 12.","DOI":"10.3390\/cancers12061351"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","article-title":"Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism","volume":"146","author":"Chao","year":"2005","journal-title":"Endocrinology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"33742","DOI":"10.1074\/jbc.M203215200","article-title":"ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein Lipase","volume":"277","author":"Shimizugawa","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/ATVBAHA.107.151894","article-title":"Angptl4 Up-regulates Cholesterol Synthesis in Liver via Inhibition of LPL- and HL-Dependent Hepatic Cholesterol Uptake","volume":"27","author":"Lichtenstein","year":"2007","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1538\/expanim.55.27","article-title":"Angptl3-null Mice Show Low Plasma Lipid Concentrations by Enhanced Lipoprotein Lipase Activity","volume":"55","author":"Fujimoto","year":"2006","journal-title":"Exp. Anim."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOL.0000000000000297","article-title":"Role of lipoprotein lipase in lipid metabolism","volume":"27","author":"Olivecrona","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_29","first-page":"4701","article-title":"Molecular modelling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain","volume":"269","author":"Kobayashi","year":"2002","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1194\/jlr.RA120000888","article-title":"Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance","volume":"61","author":"Adam","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1194\/jlr.M094128","article-title":"Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice","volume":"60","author":"Oteng","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fendo.2014.00004","article-title":"Angiopoietin-Like Proteins: A Comprehensive Look","volume":"5","author":"Santulli","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1194\/jlr.M500005-JLR200","article-title":"Differential regulation and properties of angiopoietin-like proteins 3 and 4","volume":"46","author":"Ge","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.0604026103","article-title":"Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue","volume":"103","author":"Sukonina","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jhep.2013.08.016","article-title":"Hepatitis C virus modulates lipid regulatory factor Angiopoietin-like 3 gene expression by repressing HNF-1\u03b1 activity","volume":"60","author":"Foka","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7888\/juoeh.41.317","article-title":"The Roles of ANGPTL Families in Cancer Progression","volume":"41","author":"Endo","year":"2019","journal-title":"J. UOEH"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/cam4.418","article-title":"ANGPTL3 is a novel biomarker as it activates ERK\/MAPK pathway in oral cancer","volume":"4","author":"Koyama","year":"2015","journal-title":"Cancer Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbrc.2019.06.120","article-title":"ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation","volume":"516","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00011-013-0678-0","article-title":"Role of Angptl4 in vascular permeability and inflammation","volume":"63","author":"Guo","year":"2013","journal-title":"Inflamm. Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Carbone, C., Piro, G., Merz, V., Simionato, F., Santoro, R., Zecchetto, C., Tortora, G., and Melisi, D. (2018). Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020431"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1541-7786.MCR-11-0519","article-title":"Emerging Roles of Angiopoietin-like 4 in Human Cancer","volume":"10","author":"Tan","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jgm.1519","article-title":"Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors","volume":"12","author":"Foka","year":"2010","journal-title":"J. Gene Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1194\/jlr.M300031-JLR200","article-title":"A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice","volume":"44","author":"Ando","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jhep.2005.11.010","article-title":"HCV virological assessment","volume":"44","author":"Forns","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jhep.2005.11.009","article-title":"Natural history and predictors of disease severity in chronic hepatitis C","volume":"44","author":"Massard","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/bega.1999.0071","article-title":"Natural history of HCV infection","volume":"14","author":"Poynard","year":"2000","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1871530319666190826150344","article-title":"Predictors for Fibrosis Regression in Chronic HCV Patients after the Treatment with DAAS: Results of a Real-world Cohort Study","volume":"20","author":"Soliman","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12985-018-1066-8","article-title":"Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: Results of a real-world cohort study","volume":"15","author":"Tao","year":"2018","journal-title":"Virol. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphys.2012.00012","article-title":"Biological Significance of Local TGF-\u03b2 Activation in Liver Diseases","volume":"3","author":"Hayashi","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"a021873","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-\u03b2 and the TGF-\u03b2 Family: Context-Dependent Roles in Cell and Tissue Physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s11908-017-0578-5","article-title":"Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions","volume":"19","author":"Johnson","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"a036814","DOI":"10.1101\/cshperspect.a036814","article-title":"HCV Assembly and Egress via Modifications in Host Lipid Metabolic Systems","volume":"11","author":"Shimotohno","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/hep.31500","article-title":"Hepatic Fat\u2014Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs","volume":"72","author":"Degasperi","year":"2020","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2004","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12072-019-09952-5","article-title":"The prognostic role of liver stiffness in patients with chronic liver disease: A systematic review and dose\u2013response meta-analysis","volume":"13","author":"Shen","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Axley, P., Mudumbi, S., Sarker, S., Kuo, Y.-F., and Singal, A. (2018). Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197117"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-\u03b2 in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/cld.707","article-title":"All Patients with Advanced Fibrosis Should Continue to Be Screened for Hepatocellular Carcinoma After Sustained Virological Response of Hepatitis C Virus","volume":"12","author":"Khan","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cyto.2017.03.006","article-title":"Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma","volume":"96","author":"Zidan","year":"2017","journal-title":"Cytokine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3748\/wjg.v20.i11.2777","article-title":"Role of macrophages and monocytes in hepatitis C virus infections","volume":"20","author":"Revie","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/21505594.2016.1175700","article-title":"Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency","volume":"7","author":"Foka","year":"2016","journal-title":"Virulence"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/j.gastro.2017.10.035","article-title":"Levels of Cytokines in Serum Associate with Development of Hepatocellular Carcinoma in Patients with HCV Infection Treated with Direct-Acting Antivirals","volume":"154","author":"Debes","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/hep.29911","article-title":"Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals","volume":"68","author":"Faillaci","year":"2018","journal-title":"Hepatology"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Khera, T., Du, Y., Todt, D., Deterding, K., Strunz, B., Hardtke, S., Aregay, A., Port, K., Hardtke-Wolenski, M., and Steinmann, E. (2021). Long-lasting Imprint in the Soluble Inflammatory Milieu despite Early Treatment of Acute Symptomatic Hepatitis C. J. Infect. Dis.","DOI":"10.1093\/infdis\/jiab048"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Graf, C., Welzel, T., Bogdanou, D., Vermehren, J., Beckel, A., Bojunga, J., Friedrich-Rust, M., Dietz, J., Kubesch, A., and Mondorf, A. (2020). Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092702"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/kjm2.12275","article-title":"Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication","volume":"36","author":"Huang","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21037\/atm-20-669","article-title":"Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment","volume":"9","author":"Iossa","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3851\/IMP3094","article-title":"Effect of antiviral therapy for HCV on lipid levels","volume":"22","author":"Mauss","year":"2016","journal-title":"Antivir. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jgh3.12324","article-title":"Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals","volume":"4","author":"Nevola","year":"2020","journal-title":"JGH Open"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jacl.2018.02.011","article-title":"Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated \u03c9-oxidation","volume":"12","author":"Chang","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cespiati, A., Petta, S., Lombardi, R., Di Marco, V., Calvaruso, V., Bertelli, C., Pisano, G., Fatta, E., Sigon, G., and Iuculano, F. (2020). Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP). Dig. Liver Dis.","DOI":"10.1016\/j.dld.2020.11.001"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jceh.2018.06.009","article-title":"Shalimar Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography","volume":"9","author":"Rout","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_74","first-page":"1","article-title":"Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients","volume":"9","author":"Cheng","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-Acting Antiviral\u2013Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients with Chronic Hepatitis C","volume":"214","author":"Hengst","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.M002618","article-title":"Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample","volume":"51","author":"Robciuc","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/hukin-2015-0113","article-title":"Effects of Regular Recreational Exercise Training on Serum ANGPTL3-Like Protein and Lipid Profile in Young Healthy Adults","volume":"49","author":"Smol","year":"2015","journal-title":"J. Hum. Kinet."},{"key":"ref_78","first-page":"35","article-title":"Computational Systems Biology for Aging Research","volume":"40","author":"Mooney","year":"2015","journal-title":"Interdiscip. Top. Gerontol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.20982","article-title":"Viral load as a predictor of progression of chronic hepatitis C?","volume":"42","author":"Heller","year":"2005","journal-title":"Hepatology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7476231","DOI":"10.1155\/2016\/7476231","article-title":"Clinical Impact of Viral Load on the Development of Hepatocellular Carcinoma and Liver-Related Mortality in Patients with Hepatitis C Virus Infection","volume":"2016","author":"Noh","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming Growth Factor-\u03b2-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1440-1746.2003.02985.x","article-title":"Transforming growth factor beta in hepatitis C virus infection: In vivo and in vitro findings","volume":"18","author":"Ray","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jhep.2013.07.036","article-title":"HCV core-mediated activation of latent TGF-\u03b2 via thrombospondin drives the crosstalk between hepatocytes and stromal environment","volume":"59","author":"Benzoubir","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/jir.2018.0045","article-title":"Extrahepatic Up-regulation of Transforming Growth Factor Beta 2 in HCV Genotype 4-Induced Liver Fibrosis","volume":"38","author":"Dawood","year":"2018","journal-title":"J. Interf. Cytokine Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)65595-2","article-title":"Contribution of Hepatic Parenchymal and Nonparenchymal Cells to Hepatic Fibrogenesis in Biliary Atresia","volume":"153","author":"Ramm","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGF\u03b2 Primes Breast Tumours for Lung Metastasis Seeding through Angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"54966","DOI":"10.18632\/oncotarget.18629","article-title":"TGF-\u03b22-induced ANGPTL4 expression promotes tumour progression and osteoclast differentiation in giant cell tumour of bone","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_88","unstructured":"Valiakou, V.D.A., and Foka, P. (2021). Effect of TGF-\u03b2 on ANGPTL-3 mRNA expression."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/nprot.2006.395","article-title":"Cell culture and infection system for hepatitis C virus","volume":"1","author":"Kato","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ng, T.I., Krishnan, P., Pilot-Matias, T., Kati, W., Schnell, G., Beyer, J., Reisch, T., Lu, L., Dekhtyar, T., and Irvin, M. (2017). In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.02558-16"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/gb-2014-15-4-r63","article-title":"Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta\/delta is the result of the conformational proximity of two response elements","volume":"15","author":"Inoue","year":"2014","journal-title":"Genome Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1099\/vir.0.012203-0","article-title":"Infection with herpes simplex type 1-based amplicon vectors results in an IRF3\/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts","volume":"90","author":"Tsitoura","year":"2009","journal-title":"J. Gen. Virol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/7961\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:35:02Z","timestamp":1760164502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/7961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":92,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22157961"],"URL":"https:\/\/doi.org\/10.3390\/ijms22157961","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,26]]}}}